Fairfield
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Fairfield's practice is noted for its expertise in the medical devices space, with the team often advising on high-profile regulatory matters in the industry. The group is equally strong in handling financing mandates, as well as handling instructions from clients in the pharmaceutical space. The department is jointly led by Oskar Luty, Marcin Flak, and Karol Korszuń.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- Oskar Luty is the very best there is. That being said, all his associates and partners are absolutely first-rate. Oskar is a standout expert and an indispensable asset to our team. He is incredibly smart, a fast thinker, and fundamentally practical and results-oriented. His knowledge, particularly concerning medical devices, pharmaceuticals, and clinical studies, is best-in-class. We especially value his long-standing experience and established rapport with Polish regulatory bodies. We couldn't hope for more.
- We adore the Life Sciences team at Fairfield. They are astonishingly and consistently responsive, bright, articulate, pragmatic, imaginative, knowledgeable, and always good value. Fairfield is our definitive 'go-to' legal partner for the Polish Life Sciences market. They are a specialist firm whose expertise in regulatory, reimbursement, and commercial strategy for both pharmaceuticals and medical devices is simply unparalleled. They are absolutely the best in Poland for complex, market-critical advice, consistently providing solutions that are legally watertight and commercially savvy.
Key clients
- Infarma - The Employers' Union of Innovative Pharmaceutical Companies
- Polmed - Polish Chamber of Commerce of Medical Devices